Pharma-Bio Serv Inc. (OTCMKTS:PBSV – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 2,008 shares, a growth of 109.6% from the September 30th total of 958 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 13,020 shares, the short-interest ratio is currently 0.2 days.
Pharma-Bio Serv Price Performance
Shares of Pharma-Bio Serv stock traded up $0.12 on Friday, reaching $0.52. The company had a trading volume of 150 shares, compared to its average volume of 4,516. The firm’s 50-day moving average price is $0.48 and its two-hundred day moving average price is $0.51. The firm has a market cap of $11.91 million, a price-to-earnings ratio of 52.05 and a beta of 0.69. Pharma-Bio Serv has a 1 year low of $0.32 and a 1 year high of $0.65.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc is a professional services and consulting company that supports pharmaceutical, biotechnology, medical device, and related life sciences organizations. Its work is focused on helping clients develop, implement, and maintain the technical, quality, and regulatory systems required to manufacture and commercialize healthcare products.
The company provides services that may include validation, regulatory compliance, quality assurance, engineering, technical consulting, project management, and support for manufacturing and facility-related initiatives.
Read More
- Five stocks we like better than Pharma-Bio Serv
- Starbucks Says Its Turnaround Is DoneāThe Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.
